Predictors of drug hypersensitivity in HIV infected subjects

Not Applicable

• Conditions: Drug hypersensitivity; Infection - Acquired immune deficiency syndrome (AIDS / HIV)

• Registration Number: ACTRN12605000491662
• Lead Sponsor: Monash University , NHMRC (pending)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-23
• Study Completion: 2008-06-30
• Last Update Posted: 28 June 2021

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Treatment with the antiretroviral drugs Efavirenz, Nevirapine, or Abacavir.

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identification of immunological factors increasing the risk of drug reactions[N/A]

Secondary Outcome Measures

Name	Time	Method
/A[No change]